Adma Biologics





Please Login or Register

Login|Register FREE

Stock Price
Open: 5.45
Prev. Close: 5.44
Low/Hi: 5.14 - 5.50
52-Week: 2.01 - 5.70
Equity: 132,962
90-Day Avg: 123,680
Todays Stock Vol: 77.4
20-Day (HV): 63.9
52-Week (HV): 90.1
Div. Yield:
Earnings: 13-Aug (Est.)
P/E Ratio:
Market Cap: 199.8 M
Short Int Pct: 0.0%
Pct Held By Inst.: 81.0%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADMA

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of Primary Immune Deficiency Disease (PIDD) and certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. ADMA's lead product candidate, RI-002, has completed a Phase III clinical trial in patients with PIDD and has met the primary endpoint. A BLA for RI-002 was submitted to the FDA on July 31, 2015. The company has received U.S. Patent 9,107,906.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADMA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.37811E+10 3,460 3460 0.0% 0 4 K 3721
IWC iShares Microcap ETF 991.6 M 9.91612E+08 1,365 1365 0.02% 0.0002 211 K 210729
VTI Vanguard Total Stock Market ETF 93.3 B 9.33E+10 3,629 3629 0.0% 0 437 K 437396
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.0% 2E-05 132 K 132352

Wait, Before You Leave...

Want to Know More About ADMA Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon